Hansa Biopharma AB (STU:24H) Sale Of Property, Plant, Equipment : €0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Hansa Biopharma AB Sale Of Property, Plant, Equipment?

Hansa Biopharma AB's sale of property, plant, equipment for the three months ended in Sep. 2024 was €0.00 Mil. It means Hansa Biopharma AB gained €0.00 Mil from selling property, plant, and equipment. Hansa Biopharma AB's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Sep. 2024 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Jun. 2024 ), Hansa Biopharma AB gained the same money from selling property, plant, and equipment in Sep. 2024 (€0.00 Mil).

Hansa Biopharma AB Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Hansa Biopharma AB's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansa Biopharma AB Sale Of Property, Plant, Equipment Chart

Hansa Biopharma AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Sale Of Property, Plant, Equipment

Get a 7-Day Free Trial

0.01

Hansa Biopharma AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Sale Of Property, Plant, Equipment	Get a 7-Day Free Trial															-	-	-	-	-

Hansa Biopharma AB Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Hansa Biopharma AB Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Hansa Biopharma AB's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Hansa Biopharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hansa Biopharma AB (STU:24H) » Definitions » Sale Of Property, Plant, Equipment

Comparable Companies

Traded in Other Exchanges

HNSBF:USA HNSA:Sweden 0RC7:UK 24H:Germany

Address

Scheelevagen 22, Lund, SWE, 223 63

Website

https://www.hansabiopharma.com

Hansa Biopharma AB is a biopharmaceutical company that develops immunomodulatory treatments for enabling transplantations and rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection, and cancer. The company's product candidate, imlifidase, is an antibody-cleaving enzyme being developed to enable kidney transplantation in sensitized patients and further developed for use in other organ and tissue transplantation as well as acute autoimmune indications. It operates in Sweden, other European countries, and the U.S. The group generates the majority of its revenue from product sales.

Hansa Biopharma AB Headlines

No Headlines